☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
renal diseases
Everest Enter into an Exclusive License Agreement with Sinovent and SinoMab to Develop and Commercialize XNW1011 for Renal Disease...
September 20, 2021
Bayer to Fund Five New Startup Companies as Part of G4A Digital Health Partnerships Program
November 19, 2020
Medtronic to Acquire Avenu Medical
September 30, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.